Your browser is no longer supported. Please, upgrade your browser.
FCSC Fibrocell Science, Inc. monthly Stock Chart
FCSC [NASD]
Fibrocell Science, Inc.
Index- P/E- EPS (ttm)-1.82 Insider Own0.04% Shs Outstand15.58M Perf Week-4.89%
Market Cap10.30M Forward P/E- EPS next Y-1.06 Insider Trans0.00% Shs Float14.71M Perf Month-57.63%
Income-26.80M PEG- EPS next Q-0.35 Inst Own36.20% Short Float7.37% Perf Quarter-81.33%
Sales0.04M P/S278.33 EPS this Y57.40% Inst Trans2.62% Short Ratio4.24 Perf Half Y-81.22%
Book/sh-0.23 P/B- EPS next Y51.20% ROA-144.80% Target Price7.37 Perf Year-67.11%
Cash/sh0.76 P/C0.87 EPS next 5Y- ROE-926.50% 52W Range0.61 - 4.64 Perf YTD-65.03%
Dividend- P/FCF- EPS past 5Y52.40% ROI-335.20% 52W High-85.74% Beta0.48
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low9.26% ATR0.15
Employees23 Current Ratio3.50 Sales Q/Q- Oper. Margin- RSI (14)22.36 Volatility10.66% 11.28%
OptionableYes Debt/Eq- EPS Q/Q86.70% Profit Margin- Rel Volume3.32 Prev Close0.70
ShortableYes LT Debt/Eq- EarningsNov 13 BMO Payout- Avg Volume255.67K Price0.66
Recom1.30 SMA20-44.54% SMA50-65.01% SMA200-73.96% Volume848,030 Change-5.57%
Sep-26-17Reiterated H.C. Wainwright Buy $5.70 → $7.60
Mar-07-17Initiated Rodman & Renshaw Buy $2
Mar-11-16Reiterated Wedbush Neutral $6 → $4
Dec-22-15Initiated ROTH Capital Buy $14
Sep-28-15Downgrade Wedbush Outperform → Neutral
Dec-14-17 01:22PM  ETFs with exposure to Fibrocell Science, Inc. : December 14, 2017 Capital Cube +7.23%
Dec-12-17 12:10PM  Chester County gene therapy company completes $10.5M stock sale American City Business Journals -6.12%
Dec-11-17 04:01PM  Fibrocell Announces Closing of $10.5 Million Underwritten Public Offering GlobeNewswire
Dec-08-17 07:13PM  Should You Worry About Fibrocell Science Incs (FCSC) CEO Pay Check? Simply Wall St.
Dec-07-17 11:36AM  Fibrocell Science Inc (FCSC) Feels the Heat of Share Dilution SmarterAnalyst -32.54%
07:00AM  Fibrocell Announces Pricing of $10.5 Million Underwritten Public Offering GlobeNewswire
Nov-29-17 05:57PM  Was Fibrocell Science Incs (FCSC) Earnings Growth Better Than Industry? Simply Wall St.
Nov-13-17 08:30AM  Fibrocell Science reports 3Q loss Associated Press -6.82%
08:00AM  Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights GlobeNewswire
06:05AM  Fibrocell Science, Inc. to Host Earnings Call ACCESSWIRE
Nov-10-17 08:49AM  Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss Zacks
Nov-09-17 12:06AM  New Skin for 7-Year-Old Boy Marks Advance in Gene Therapy The Wall Street Journal +7.69%
Nov-08-17 01:09PM  New Skin for 7-Year-Old Boy Marks Advance in Gene Therapy The Wall Street Journal
Nov-06-17 08:00AM  Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 Financial Results and Recent Operational Highlights GlobeNewswire -9.27%
Oct-31-17 05:58PM  What's in Store for Intrexon (XON) This Earnings Season? Zacks
Oct-02-17 04:30PM  Fibrocell to Present at 2017 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-26-17 08:00AM  Fibrocell Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire -6.21%
Sep-22-17 09:00AM  Implied Volatility Surging for Fibrocell Science (FCSC) Stock Options Zacks -6.27%
Sep-05-17 08:00AM  Fibrocell to Present at Rodman & Renshaw 19th Annual Global Investment Conference and Global Genes 2017 RARE Patient Advocacy Summit GlobeNewswire -5.58%
Aug-09-17 10:25PM  Fibrocell Science reports 2Q loss Associated Press -5.07%
08:00AM  Fibrocell Reports Second Quarter 2017 Financial Results and Recent Highlights GlobeNewswire
05:30AM  Investor Network: Fibrocell Science, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 08:00AM  Fibrocell to Present at Canaccord Genuity 37th Annual Growth Conference GlobeNewswire
Aug-02-17 10:26AM  What's in Store for Intrexon (XON) in this Earnings Season? Zacks
08:00AM  Fibrocell to Host Conference Call and Webcast on Wednesday, August 9, 2017 to Discuss Second Quarter 2017 Financial Results and Recent Operational Highlights GlobeNewswire
Jun-20-17 08:15AM  Fibrocell Science (FCSC) Looks Good: Stock Moves Up 13.9% Zacks -5.40%
Jun-12-17 08:00AM  Fibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized Scleroderma GlobeNewswire +14.80%
Jun-08-17 08:00AM  Fibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
May-17-17 08:00AM  Fibrocell to Present at Inaugural Cell & Gene Exchange 2017 GlobeNewswire
May-10-17 08:32AM  Fibrocell Science reports 1Q loss Associated Press
08:00AM  Fibrocell Reports First Quarter 2017 Financial Results and Recent Operational Highlights GlobeNewswire
07:00AM  Investor Network: Fibrocell Science, Inc. to Host Earnings Call Accesswire
May-09-17 09:14AM  Fibrocell and Intrexon Announce Two Oral Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy GlobeNewswire
May-08-17 08:00AM  Fibrocell Announces Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
May-03-17 08:00AM  Fibrocell to Host Conference Call and Webcast on Wednesday, May 10, 2017 to Discuss First Quarter 2017 Financial Results and Recent Operational Highlights GlobeNewswire
Apr-13-17 08:00AM  Fibrocell to Present at 7th Annual World Orphan Drug Congress USA 2017 and 5th Annual Cell & Gene Therapy Investor Day GlobeNewswire +9.30%
Apr-07-17 04:33PM  ETFs with exposure to Fibrocell Science, Inc. : April 7, 2017 Capital Cube
Mar-28-17 08:00AM  Fibrocell Regains Compliance with NASDAQ Listing Requirements GlobeNewswire
Mar-20-17 08:37AM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube -5.88%
08:37AM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-15-17 01:14PM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
01:14PM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
01:04PM  FIBROCELL SCIENCE, INC. Financials
Mar-10-17 09:03AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articl
09:00AM  Fibrocell Announces One-for-Three Reverse Stock Split GlobeNewswire
Mar-09-17 08:06AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
08:00AM  Fibrocell Reports 2016 Financial Results and Recent Operational Highlights GlobeNewswire
07:07AM  Q4 2016 Fibrocell Science Inc Earnings Release - Before Market Open
Mar-08-17 05:17PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fin +7.03%
Mar-07-17 05:15PM  Fibrocell to Host Conference Call and Webcast on Thursday, March 9, 2017 to Discuss 2016 Financial Results and Recent Operational Highlights GlobeNewswire +17.13%
04:54PM  Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million GlobeNewswire
07:05AM  Coverage initiated on Fibrocell Science by Rodman & Renshaw
Mar-03-17 05:28PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
Mar-01-17 05:10PM  Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results PR Newswire
05:01PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Feb-23-17 08:06AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Fibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
Feb-13-17 08:02AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-26-17 04:39PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
Jan-09-17 08:02AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-05-17 08:02AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +24.78%
08:00AM  Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
Dec-19-16 08:03AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
08:00AM  Fibrocell Announces Leadership Changes GlobeNewswire
Dec-14-16 01:02PM  ETFs with exposure to Fibrocell Science, Inc. : December 14, 2016 -7.32%
Dec-02-16 12:18PM  ETFs with exposure to Fibrocell Science, Inc. : December 2, 2016
Nov-10-16 12:20PM  ETFs with exposure to Fibrocell Science, Inc. : November 10, 2016 +18.18%
08:30AM  Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor GlobeNewswire
Nov-09-16 04:19PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers -8.35%
Nov-08-16 11:25AM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016
Nov-03-16 11:26AM  Fibrocell Science reports 3Q loss
08:02AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
08:00AM  Fibrocell Reports Third Quarter 2016 Financial Results and Recent Operational Highlights GlobeNewswire
07:07AM  Q3 2016 Fibrocell Science Inc Earnings Release - Before Market Open
Oct-31-16 04:01PM  Fibrocell to Host Conference Call and Webcast on Thursday, November 3, 2016 to Discuss Third Quarter 2016 Financial Results and Recent Operational Highlights GlobeNewswire -5.63%
Oct-24-16 12:20PM  ETFs with exposure to Fibrocell Science, Inc. : October 24, 2016 -5.33%
Oct-12-16 09:47AM  ETFs with exposure to Fibrocell Science, Inc. : October 12, 2016 +11.68%
Oct-11-16 12:05PM  Fibrocell Science, Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia Accesswire -9.08%
Oct-05-16 04:05PM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta +12.22%
Sep-29-16 08:00AM  Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-27-16 10:00AM  ETFs with exposure to Fibrocell Science, Inc. : September 27, 2016
Sep-19-16 08:00AM  Fibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
Sep-15-16 10:00AM  ETFs with exposure to Fibrocell Science, Inc. : September 15, 2016
Sep-08-16 09:29AM  Fibrocell Announces Closing of $18 Million Private Placement GlobeNewswire
09:20AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia
Aug-23-16 11:49AM  ETFs with exposure to Fibrocell Science, Inc. : August 23, 2016
Aug-11-16 12:45PM  ETFs with exposure to Fibrocell Science, Inc. : August 11, 2016
Aug-09-16 01:30PM  Gene therapy company scraps public stock offering for private financing at bizjournals.com +16.42%
12:31PM  Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
08:32AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia
08:30AM  Fibrocell Announces Convertible Debt and Warrant Financing of Up to $25 Million GlobeNewswire
Aug-08-16 04:30PM  Fibrocell Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
Aug-04-16 12:16PM  Conatus (CNAT) Posts Narrower Q2 Loss, Emricasan in Focus
09:06AM  Fibrocell Science reports 2Q loss
08:01AM  FIBROCELL SCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
08:01AM  Fibrocell Reports Second Quarter 2016 Financial Results and Recent Operational Highlights GlobeNewswire
07:07AM  Q2 2016 Fibrocell Science Inc Earnings Release - Before Market Open
Aug-03-16 10:52AM  Zoetis (ZTS) Beats on Q2 Earnings & Revenues, Lifts Outlook
Jul-28-16 12:11PM  Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
08:01AM  Fibrocell to Host Conference Call and Webcast on Thursday, August 4, 2016 to Discuss Second Quarter 2016 Financial Results and Recent Operational Highlights GlobeNewswire
Fibrocell Science, Inc., an autologous cell and gene therapy company, focuses on discovering and developing therapies for diseases affecting the skin, connective tissues, and joints in the United States. The company's gene-therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, which is in pre-clinical development stage for the treatment of linear scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions. It has collaboration agreement with Intrexon Corporation for the development of FCX-007, FCX-013, and products for the treatment of chronic inflammation and degenerative diseases of human joints. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was incorporated in 1992 and is based in Exton, Pennsylvania.